Past, Present and Future of Chemodenervation With Botulinum Toxin in the Treatment of Overactive Bladder

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.11.092
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Botulinum Toxin-A for the Treatment of Overactive Bladder: UK Contributions

Journal of Clinical Urology
SurgeryUrology
2013English

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome

International Neurourology Journal
NeurologyUrology
2015English

Botulinum Toxin Therapy for Nonneurogenic Overactive Bladder: First Experience

Acta medica Lituanica
2011English

The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial

Contemporary Clinical Trials
MedicinePharmacology
2014English

A Comparative Study Between Sacral Neuromodulation and Intravesical Botulinum Toxin Injection for Patients With Refractory Overactive Bladder

Arab Journal of Urology
Urology
2020English

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type a Treatment

European Urology
Urology
2009English

A Review of Botulinum Toxin a for the Treatment of Neurogenic Bladder

PM and R
Physical TherapySports ScienceSports TherapyNeurologyMedicineRehabilitation
2019English

Botulinum Toxin Chemodenervation for Childhood Strabismus in England: National and Local Patterns of Practice

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy